Screener
Galectin Therapeutics GALT Q4 2025 Annual earnings
Reported March 31, 2026
EPS-$0.08Beat by $0.02
Revenue estimate$36.3M
EPS estimate-$0.10
Next report
Nov 13, 2026 (in 2 months)EPS estimate-$0.05
Versus estimates
Diluted EPS
FAQ
- When did Galectin Therapeutics report Q4 2025 earnings?
- Galectin Therapeutics (GALT) reported Q4 2025 earnings on March 31, 2026.
- What were Galectin Therapeutics's Q4 2025 revenue and EPS?
- Galectin Therapeutics reported eps of $-0.08 for Q4 2025.
- Did Galectin Therapeutics beat estimates in Q4 2025?
- EPS beat the consensus estimate of $-0.10 by $0.02.
- How did Galectin Therapeutics's Q4 2025 results compare year-over-year?
- Compared to the same quarter a year prior, eps grew 57.9% from $-0.19.
- Where can I find Galectin Therapeutics's Q4 2025 SEC filings?
- You can read the 8-K earnings release (0001140361-26-012158) and the 10-K periodic report (0001140361-26-012155) directly on SEC EDGAR. The filing index links above go to sec.gov.
